Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events

Autor: Nizam, Amanda, Rader, Ryan K., Tzeng, Alice, Wei, Wei, Sheng, Iris Yeong-Fung, Martin, Allison, Wee, Christopher E., Gilligan, Timothy D., Gupta, Shilpa, Ornstein, Moshe C.
Zdroj: In Clinical Genitourinary Cancer April 2024 22(2):368-379
Databáze: ScienceDirect
Externí odkaz: